Literature DB >> 26201637

A nationwide population-based study shows increasing incidence of cholangiocarcinoma.

Teng-Yu Lee1,2,3, Jaw-Town Lin4,5,6, Ken N Kuo6, Ming-Shiang Wu4, Hsiu J Ho2, Tzu-Ting Chen2, Chun-Ying Wu7,8,9,10.   

Abstract

PURPOSE: An increasing incidence of cholangiocarcinoma (CCA) has been reported in Western countries, but evidence is lacking in Asia. We investigated the incidence of CCA in a nationwide cohort. PATIENTS AND METHODS: We conducted a nationwide cohort study based on data from the Taiwan National Health Insurance Research Database (NHIRD) between 1998 and 2008. A total of 6,491 CCA patients were recruited. Adjusted incidences, cumulative incidences, and stratified analyses were used to detect trends regarding CCA incidence in Taiwan.
RESULTS: The incidence of CCA increased by 2.01-fold, from 1.79 in 1998 to 3.60 in 2008 per 100,000 persons. For extrahepatic CCA, the incidence increased by 1.5-fold from 0.48 to 0.73 per 100,000. Intrahepatic CCA increased by 3.0-fold from 0.72 to 2.19 per 100,000. The rising incidence of CCA was observed across all sexes and ages, especially in those older than 65 years of age. The proportion of CCA patients who underwent surgery and the overall survival rates remained stable.
CONCLUSIONS: The incidence of both intrahepatic and extrahepatic CCA increased significantly between 1998 and 2008. Rising trends were observed among different ages and sexes, especially in the elderly population.

Entities:  

Keywords:  Epidemiology; Hepatobiliary cancers; Liver tumors

Year:  2012        PMID: 26201637     DOI: 10.1007/s12072-012-9369-0

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  25 in total

1.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

2.  Evolution of Taiwan's health care system.

Authors:  Jui-Fen Rachel Lu; Tung-Liang Chiang
Journal:  Health Econ Policy Law       Date:  2010-03-04

Review 3.  Risk factors for cholangiocarcinoma.

Authors:  Gia L Tyson; Hashem B El-Serag
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

4.  Descriptive epidemiology of cholangiocarcinoma in Italy.

Authors:  Domenico Alvaro; Emanuele Crocetti; Stefano Ferretti; Maria Consiglia Bragazzi; Riccardo Capocaccia
Journal:  Dig Liver Dis       Date:  2009-12-22       Impact factor: 4.088

Review 5.  Epidemiology of cholangiocarcinoma: an update focusing on risk factors.

Authors:  Hai-Rim Shin; Jin-Kyoung Oh; Eric Masuyer; Maria-Paula Curado; Veronique Bouvard; Yue-Yi Fang; Surapon Wiangnon; Banchob Sripa; Sung-Tae Hong
Journal:  Cancer Sci       Date:  2009-12-04       Impact factor: 6.716

6.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 7.  Cholangiocarcinoma: update and future perspectives.

Authors:  Manuela Gatto; Maria Consiglia Bragazzi; Rossella Semeraro; Cristina Napoli; Raffaele Gentile; Alessia Torrice; Eugenio Gaudio; Domenico Alvaro
Journal:  Dig Liver Dis       Date:  2010-01-22       Impact factor: 4.088

8.  Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.

Authors:  Yasser H Shaib; Jessica A Davila; Louise Henderson; Katherine A McGlynn; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2007 Nov-Dec       Impact factor: 3.062

9.  A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use.

Authors:  Chun-Ying Wu; Chia-Hsuan Wu; Ming-Shiang Wu; Chang-Bi Wang; Jur-Shan Cheng; Ken N Kuo; Jaw-Town Lin
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-11       Impact factor: 11.382

10.  Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.

Authors:  J West; H Wood; R F A Logan; M Quinn; G P Aithal
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

View more
  3 in total

1.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

2.  Trends in surgery and disparities in receipt of surgery for intrahepatic cholangiocarcinoma in the US: 2005-2014.

Authors:  Eke Ransome; Li Tong; Jairo Espinosa; Jesse Chou; Vishal Somnay; Gitonga Munene
Journal:  J Gastrointest Oncol       Date:  2019-04

3.  Identification of Novel Ribonucleotide Reductase Inhibitors for Therapeutic Application in Bile Tract Cancer: An Advanced Pharmacoinformatics Study.

Authors:  Md Ataul Islam; Mayuri Makarand Barshetty; Sridhar Srinivasan; Dawood Babu Dudekula; V P Subramanyam Rallabandi; Sameer Mohammed; Sathishkumar Natarajan; Junhyung Park
Journal:  Biomolecules       Date:  2022-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.